Announcements Trials
Browse Landscape

Phase

Phase 1 30Phase 2 8Phase 1/2 6Phase NA 1Phase 3 1

Status

Recruiting 4Unknown 1Terminated 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 105Breast 37Tumor-Agnostic 8Thoracic 6Other solid neoplasm 6Head & Neck 6CNS 6Genitourinary 4Lymphoid 3Gynecologic 3Dermatologic 3Sarcoma 2Plasma cell 1

Conditions

Advanced Solid Tumors 3Solid Tumor 1Childhood Solid Tumor 1Advanced Solid Tumor 1

Interventions

pembrolizumab 41Injections 39toripalimab 23Nivolumab 22Cisplatin 19Pemetrexed 18Carboplatin 18Cyclophosphamide 17Paclitaxel 14Bevacizumab 14fludarabine 12Gemcitabine 11tislelizumab 10Ipilimumab 10spartalizumab 9Irinotecan 9atezolizumab 8Docetaxel 8Oxaliplatin 7Leucovorin 7Fluorouracil 7Capecitabine 6sintilimab 5Interleukin-2 5Albumin-Bound Paclitaxel 5130-nm albumin-bound paclitaxel 5trifluridine tipiracil drug combination 4sotorasib 4pazopanib 4palbociclib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Capecitabine × Other solid neoplasm × Clear all
NCT03585465 2026-05-29

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Terminated
63 enrolled
Other solid neoplasm

Childhood Solid Tumor

NCT06741644 2026-04-15

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

CStone Pharmaceuticals

Phase 1/2 Recruiting
660 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06703177 2025-12-03

A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 1/2 Recruiting
876 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06208410 2025-07-25

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

Risen (Suzhou) Pharma Tech Co., Ltd.

Phase 1/2 Recruiting
306 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06139211 2024-12-20

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

Shanghai Junshi Bioscience Co., Ltd.

Phase 1/2 Recruiting
186 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06041035 2023-09-18

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Unknown
115 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡